3,7-di(cyclopropylmethyl)spiro[3,7-diazabicyclo[3.3.1]nonane-9,1'-cyclopentane]

ID: ALA2111110

Chembl Id: CHEMBL2111110

Max Phase: Phase

Molecular Formula: C19H32N2

Molecular Weight: 288.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: KC-8857 | KC8857

Synonyms from Alternative Forms(4): Tedisamil sesquifumarate | Pulzium | KC-8857 SESQUIFUMARATE | KC8857

Canonical SMILES:  C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1

Standard InChI:  InChI=1S/C19H32N2/c1-2-8-19(7-1)17-11-20(9-15-3-4-15)12-18(19)14-21(13-17)10-16-5-6-16/h15-18H,1-14H2/t17-,18+

Standard InChI Key:  CTIRHWCPXYGDGF-HDICACEKSA-N

Alternative Forms

  1. Alternative Forms:

  2. Parent:

    ALA2111110

    TEDISAMIL

Associated Targets(Human)

SCN1A Tclin Sodium channel alpha subunit (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cavia porcellus (23802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 288.48Molecular Weight (Monoisotopic): 288.2565AlogP: 3.23#Rotatable Bonds: 4
Polar Surface Area: 6.48Molecular Species: BASEHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.26CX LogP: 2.78CX LogD: 0.65
Aromatic Rings: Heavy Atoms: 21QED Weighted: 0.78Np Likeness Score: 0.02

References

1. Schön U, Antel J, Brückner R, Messinger J, Franke R, Gruska A..  (1998)  Synthesis, pharmacological characterization, and quantitative structure-activity relationship analyses of 3,7,9,9-tetraalkylbispidines: derivatives with specific bradycardic activity.,  41  (3): [PMID:9464363] [10.1021/jm970120q]
2. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
3. Mirams GR, Cui Y, Sher A, Fink M, Cooper J, Heath BM, McMahon NC, Gavaghan DJ, Noble D..  (2011)  Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.,  91  [PMID:21300721] [10.1093/cvr/cvr044]
4. WHO Anatomical Therapeutic Chemical Classification, 
5. Unpublished dataset,